Purinergic receptor-induced Ca2+ signaling in the neuroepithelium of the vomeronasal organ of larval Xenopus laevis by Katarina Dittrich et al.
ORIGINAL ARTICLE
Purinergic receptor-induced Ca2+ signaling
in the neuroepithelium of the vomeronasal organ
of larval Xenopus laevis
Katarina Dittrich & Alfredo Sansone &
Thomas Hassenklöver & Ivan Manzini
Received: 19 September 2013 /Accepted: 4 November 2013 /Published online: 23 November 2013
# The Author(s) 2013. This article is published with open access at Springerlink.com
Abstract Purinergic signaling has considerable impact on the
functioning of the nervous system, including the special
senses. Purinergic receptors are expressed in various cell types
in the retina, cochlea, taste buds, and the olfactory epithelium.
The activation of these receptors by nucleotides, particularly
adenosine-5′-triphosphate (ATP) and its breakdown products,
has been shown to tune sensory information coding to control
the homeostasis and to regulate the cell turnover in these
organs. While the purinergic system of the retina, cochlea,
and taste buds has been investigated in numerous studies, the
available information about purinergic signaling in the olfac-
tory system is rather limited. Using functional calcium imag-
ing, we identified and characterized the purinergic receptors
expressed in the vomeronasal organ of larval Xenopus laevis .
ATP-evoked activity in supporting and basal cells was not
dependent on extracellular Ca2+. Depletion of intracellular
Ca2+ stores disrupted the responses in both cell types. In
addition to ATP, supporting cells responded also to uridine-
5 ′ - t r i phospha t e (UTP) and adenos ine -5 ′ -O- (3 -
thiotriphosphate) (ATPγS). The response profile of basal cells
was considerably broader. In addition to ATP, they were
activated by ADP, 2-MeSATP, 2-MeSADP, ATPγS, UTP,
and UDP. Together, our findings suggest that supporting cells
express P2Y2/P2Y4-like purinergic receptors and that basal
cells express multiple P2Y receptors. In contrast, vomeronasal
receptor neurons were not sensitive to nucleotides, suggesting
that they do not express purinergic receptors. Our data provide
the basis for further investigations of the physiological role of
purinergic signaling in the vomeronasal organ and the olfac-
tory system in general.
Keywords P2Y receptors . Olfactory system . Calcium
imaging . Pharmacological characterization
Introduction
The vomeronasal system is present as a discrete sensory system
only in tetrapods. It first appeared in amphibians ([1, 2] but see
[3]), and it is present from larval to adult stages in most
amphibian species [4]. The vomeronasal organ (VNO) is the
peripheral sensory organ of the vertebrate accessory olfactory
system [5]. The VNO has been shown to mediate the detection
of pheromones [4, 5], but in Xenopus its function still remains
to be elucidated. It consists of a neuroepithelium containing the
same three main cell types as the vertebrate main olfactory
epithelium (MOE): (1) receptor neurons which transmit the
sensory information from the periphery to the accessory olfac-
tory bulb in the brain, (2) supporting cells (SCs) which share
common properties with glial and epithelial cells, and (3) basal
cells (BCs), stem cells which maintain the regenerative capac-
ity of the organ. Specifically, the VNO of larval Xenopus laevis
is made ofmicrovillous vomeronasal receptor neurons (VRNs),
ciliated SCs, and a population of BCs. The Xenopus MOE, in
contrast, consists of microvillous and ciliated olfactory receptor
neurons (ORNs), ciliated and secretory SCs, and a population
of BCs; for a more detailed overview of the cellular organiza-
tion of the Xenopus olfactory organ, see [1, 6].
It has been shown that SCs and BCs in the Xenopus and
mouse MOE express purinergic receptors [7–10]. In both
species, application of nucleotides to the MOE induces strong
wave-like intracellular Ca2+ ([Ca2+]i) increases in SCs that
propagate from the apical to the basal part of the MOE [8,
11], suggesting that they are a common feature of the
K. Dittrich :A. Sansone : T. Hassenklöver : I. Manzini (*)
Institute of Neurophysiology and Cellular Biophysics, University of
Göttingen, Humboldtallee 23, 37073 Göttingen, Germany
e-mail: imanzin@gwdg.de
T. Hassenklöver : I. Manzini
Center for Nanoscale Microscopy and Molecular Physiology of the
Brain (CNMPB), 37073 Göttingen, Germany
Purinergic Signalling (2014) 10:327–336
DOI 10.1007/s11302-013-9402-3
vertebrate MOE. In Xenopus , these Ca2+ waves have been
shown to be triggered by P2Y2/P2Y4-like purinergic receptors
[8]. Based on these results, it has been hypothesized that SCs
could constitute a transepithelial information path that carries
information from the apical to the basal part of the MOE.
Nucleotides released from damaged or dying ORNs could
initiate Ca2+ waves in nearby SCs, which then, carry this
information to the BCs. The elevated [Ca2+]i in the basal
endings of SCs could then stimulate nucleotide release in the
basal cell layer, thereby activating proliferation of new neurons
(for a review see [12]). In fact, it has been shown that BCs in
Xenopus express multiple P2Y receptors and that purinergic
signaling influences the cell turnover in the MOE [9]. Also, in
the mouse MOE activation of purinergic receptors induces
proliferation and neuronal differentiation [13, 14]. It is known
that purinergic signaling is generally involved in embryonic
and adult neurogenesis [15, 16], and also cells of neurogenic
brain areas in Xenopus have been shown to express purinergic
receptors [17]. In contrast to SCs and BCs, big differences
regarding the expression of purinergic receptors exist between
murine and amphibian ORNs. While murine ORNs have been
shown to express P2X and P2Y receptors [10, 18], ORNs of
Xenopus do not express purinergic receptors [7, 8]. The acti-
vation of purinergic receptors in mouse ORNs has been shown
to reduce their responsiveness to odorants [10].
In contrast to theMOE, very little is known about purinergic
signaling in the VNO. To our knowledge, there are only two
studies describing purinergic receptors in the VNO. These
studies showed that murine VRNs express P2X receptors [18,
19], and SCs in the rat VNO express P2Y receptors [18].
Activation of P2X receptors in the mouse VNO leads to an
increase of the chemosensory response in VRNs [19].
The present study was aimed to functionally identify the
purinergic receptor subtypes expressed in the various cell types
of the epithelium of the VNO of larval X. laevis . We provide
evidence that SCs express P2Y2/P2Y4-like purinergic receptors
and BCs expressmultiple P2Y receptors. Vomeronasal receptor
neurons are not sensitive to nucleotides, suggesting that they do
not express purinergic receptors. Thus, the purinergic system of
theXenopus vomeronasal epithelium appears to be very similar
to the purinergic system of the MOE [8, 9], suggesting that
purinergic receptors might have similar functional effects in
both olfactory subsystems.
Material and methods
Preparation of acute Fluo-4 stained slices of the vomeronasal
epithelium
Larval X. laevis (stages 51 to 54; staged after [20]) were
cooled in iced water to produce complete immobility and
killed by transection of the brain at its transition to the spinal
cord, as approved by the Göttingen University Committee for
Ethics in Animal Experimentation. A block of tissue contain-
ing the olfactory system was cut out and cut horizontally into
130–140 μm thick slices with a vibrotome (VT 1200S, Leica,
Bensheim, Germany). Tissue slices were loaded with the
Ca2+-sensitive dye Fluo-4/AM (Molecular Probes, Leiden,
The Netherlands) as described in previous work (see [8]).
Calcium imaging of nucleotides responses was carried out as
described below.
Ca2+ imaging and data evaluation
Changes of intracellular calcium concentrations of cells of
the epithelium of the VNO were monitored using an upright
confocal laser-scanning microscope (LSM 780/Axio Exam-
iner, Zeiss, Jena, Germany). Fluorescence images (excitation
at 488 nm; emission >495 nm) of the VNO were acquired
at 1 Hz, with about 5–10 images taken as control before the
onset of stimulus delivery. The thickness of the optical
slices excluded fluorescence detection from more than one
cell layer. Image analysis was performed using custom
programs written in MATLAB (MathWorks, Natick, USA).
To facilitate the selection of regions of interest, a “pixel
correlation map” was obtained (see [21]). The fluorescence
changes for individual cells are given as ΔF /F values. For
more detailed information, see our previous work [8]. Av-
eraged data are presented as mean ± standard error of the
mean (SEM). Statistical significance was determined by
paired Student’s t test. Maximum amplitude values of
purinergic agonist applications were normalized to an ATP
control application.
Solutions and stimulus application
Standard bath solution consisted of (in millimolar): 98 NaCl, 2
KCl, 1 CaCl2, 2 MgCl2, 5 glucose, 5 Na-pyruvate, 10
hydroxyethyl piperazineethanesulfonic (HEPES), 230
mOsmol/l, pH 7.8. Ca2+-free bath solution consisted of (in
millimolar): 98 NaCl, 2 KCl, 2 MgCl2, 5 glucose, 5 Na-
pyruvate, 10 HEPES, 2 EGTA, 230 mOsmol, pH 7.8. High
K+ bath solution consisted of (in millimolar): 17 NaCl, 80 KCl,
1 CaCl2, 2 MgCl2, 5 glucose, 5 Na-pyruvate, 10 HEPES, 230
mOsmol/l, and pH 7.8. The BrdU; uridine-5′-diphosphate
(UDP); UTP; adenosine; adenosine-5′-diphosphate (ADP);
ATP; 2-methylthio-ATP (2-MeSATP); ATPγS; 2-methylthio-
ADP (2-MeSADP); suramin, 3′-O-(4-benzoyl)benzoyl ATP
(BzATP), α,β-methylene ATP (α,β-meATP); β,γ-methylene
ATP (β,γ-meATP), cyclopiazonic acid (CPA), and bath solu-
tion chemicals were purchased from Sigma (Seelze, Germany).
Bath solution was applied by gravity feed from a storage
syringe through a funnel drug applicator to the recording
chamber. The purinergic agonists were pipetted directly into
the funnel without stopping the flow. During each application,
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1 ml of agonist solution was applied into the funnel within
about 2 s. Outflowwas through a syringe needle placed close to
the basal regions of the vomeronasal epithelium. Suramin and
CPA were added to the bath solution where indicated. The
minimum interstimulus interval between agonist applications
was at least 3min in all of the experiments. Theminimumwash
time after application of Ca2+-free bath solution, CPA and
suramin was 3–6 min.
Preparation of backfilled slices, BrdU injections,
and immunohistochemistry
To backfill VRNs, larval X. laevis (stages 51 to 54) were
anesthetized in 0.02 % MS-222 (Ethyl 3-aminobenzoate
methanesulfonate; Sigma), and their olfactory nerves were
transected. Biocytin (ε-biotinoyl-L-lysine, Molecular Probes)
or micro-Ruby (Life Technologies, Darmstadt, Germany) crys-
tals were put into the lesioned nerve, and the lesion was closed
with tissue adhesive (Histoacryl L, Braun, Tuttingen, Germa-
ny). After 1 h the animals were killed, and a tissue block (see
above) was cut out. Tissue blocks of micro-Ruby backfilled
animals were then sliced and stained with Fluo-4 as described
above. To visualize the micro-Ruby-stained VRNs, we ac-
quired fluorescence images of the VNO using the same confo-
cal laser-scanning microscope as for the calcium imaging ex-
periments (excitation at 561 nm; emission >565 nm). The
combination of VRN-staining with micro-Ruby on the one
hand and calcium imaging of nucleotide responses on the other
allowed to differentiate between responses of neuronal (VRNs)
and non-neuronal (BCs and SCs) cells. To test the viability of
the VRNs, we applied high K+ bath solution. All cells
responding with a transient increase of fluorescence were con-
sidered healthy.
To stain cells in the S phase of their cell cycle, we injected
200 μM 5-bromo-2′-deoxyuridine (BrdU, Sigma) intraperito-
neally. After 2 h, the animals were sacrificed and a tissue block
containing the vomeronasal organ and the olfactory bulb was
removed.
For immunohistochemistry, the tissue blocks were fixed in
4 % formaldehyde, washed in phosphate-buffered saline
(PBS), embedded in 5 % low melting point agarose (Sigma),
and sectioned on the vibratome at 70 μm. Sections were
washed in PBS containing 0.2 % Triton X-100 (PBST), and
non-specific binding was blocked with 2% normal goat serum
(NGS; ICN, Aurora, OH, USA) in PBST for 1 h. Slices of
BrdU-treated animals were incubated in 1 N HCl at 37 °C for
45 min to denature DNA. Slices were incubated overnight at
4 °C with primary antibodies [anti X. laevis cytokeratin II
(1h5, monoclonal, derived frommouse), or anti BrdU (B2531,
monoclonal, derived from mouse, Sigma), diluted in 2 %
NGS/PBST, all 1:1,000]. The X. laevis cytokeratin type II
antibody developed by Michael Klymkowsky was obtained
from the Developmental Studies Hybridoma Bank developed
under the auspices of the NICHD and maintained by the
University of Iowa, Department of Biological Sciences, Iowa
City, IA 52242. Primary antibodies were washed off with
PBS, and Alexa 546 conjugated streptavidin (Molecular
Probes) was applied at a final concentration of 5 μg/ml in
PBST for 5 h to visualize the biocytin backfilled VRNs. Slices
were repeatedly rinsed in PBS, and Alexa 488 conjugated goat
anti mouse secondary antibody (Molecular Probes) was ap-
plied at a dilution of 1:250 in 1 % NGS/PBS for 1.5 h. The
secondary antibodies were washed off in several changes of
PBS. Cell nuclei were stained with propidium iodide (1 μg/
ml). Slices were transferred to slides, mounted in mounting
medium (Dako, Hamburg, Germany) and visualized using a
laser-scanning confocal microscope (Zeiss LSM 510/Axiovert
100 M, Jena, Germany).
Results
Cellular organization of the epithelium of the vomeronasal
organ
To visualize the various cell types of the neuroepithelium of the
VNO of larval X. laevis , we backfilled VRNs with biocytin
through the olfactory nerve (Fig. 1a), and stained SCs with
antibodies against cytokeratin (Fig. 1b). In the MOE of larval
Xenopus , antibodies against cytokeratin exclusively label SCs
[8]. When merging both pictures (Fig. 1c) the stratification of
the OE becomes evident. The apical layer of the vomeronasal
epithelium consists of somata of SCs (Fig. 1c and e) and
dendrites of VRNs (Fig. 1c and d). The SC somata form the
columnar supporting cell layer (SCL). Supporting cells extend
thin cytoplasmatic appendages across the entire vomeronasal
epithelium that terminate in endfoot-like structures at the level
of the basal lamina (Fig. 1e). Somata of VRNs reside in the
middle part of the epithelium and form the vomeronasal recep-
tor neuron layer (VRNL). The most basal layer of the epithe-
lium (basal cell layer, BCL) is devoid of mature VRNs and
harbors vomeronasal stem cells, so-called BCs. To visualize
proliferative BCs, we adopted a BrdU incorporation assay
(Fig. 1f). A higher magnification of a part of the same epithe-
lium as shown in Fig. 1f clearly depicts a number of BrdU-
positive BCs (Fig. 1g). Most BrdU-positive cells are in the
basalmost layer of the epithelium. The few BrdU-positive cells
in the VRNL most probably are immature, migrating VRNs,
and the two BrdU-positive cells in the SCL, on the other hand,
could represent newly divided SCs (Fig. 1g).
ATP-induced increases of [Ca2+]i in cells of the vomeronasal
epithelium
Application of ATP (100 μM) to acute slices of the VNO
stained with Fluo-4 led to transient cellular Ca2+ responses,
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mainly in the SCL and the BCL. Thereby, the responses of
SCs exhibited a wave-like pattern propagating from the
apical to the basal part of the epithelium (data not shown).
The pseudocolored images of Fig. 2a show a slice of the
VNO before, at the peak of and after recovery of the ATP-
induced response. The correlation map (see Material and
methods) in the lower right corner shows all responsive
cells of this slice. The response time courses of all ATP-
sensitive cells of the SCL and the BCL of this slice are
plotted in Fig. 2b and c, respectively. Virtually identical
results were obtained with all VNO slices tested for their
responsiveness to ATP. Cells in the VRNL showed virtually
no response to ATP, indicating that neuronal cells of the
VNO do not express purinergic receptors.
To substantiate this indication, in a set of experiments,
VRNs were backfilled with micro-Ruby previous to tissue
slicing and Fluo-4 staining (see Materials and methods).
Figure 3a shows an example of a micro-Ruby backfilled and
Fluo-4 stained acute slice of the VNO. The red (micro-Ruby)
VRNs can easily be distinguished from the other cells.
Figure 3b and c, respectively, show responses to ATP and to
application of high-K+ bath solution of neuronal (VRNs) and
non-neuronal (SCs and BCs) cells. The two cell populations
showed an opposite response pattern. Vomeronasal receptor
neurons responded to the application of high K+ bath solution,
but did not respond to ATP (100 μM), non-neuronal cells of
the BCL and SCL responded to ATP but not to high K+
solution. Virtually identical results were obtained with all
micro-Ruby backfilled slices (39 VRNs and 42 non-
neuronal cells, 4 VNO slices). This clearly suggests that
BCs and SCs, but not VRNs, express purinergic receptors.
Pharmacological characterization of the purinergic receptor(s)
expressed in the vomeronasal organ
To find out whether metabotropic and/or ionotropic purinergic
receptors are involved in the ATP-induced [Ca2+]i increases in
SCs and BCs, we first examined whether the presence of
Fig. 1 Morphological organization of the epithelium of the vomeronasal
organ of larval Xenopus laevis . a Slice of a VNO with biocytin-
streptavidin-stained VRNs (SCL supporting cell layer; VRNL
vomeronasal receptor neuron layer; BCL basal cell layer). b Supporting
cell staining with an antibody against cytokeratin type II of the same slice.
c Overlay of VRNs (a red fluorescence) and SCs (b green fluorescence).
Basal cells are biocytin-streptavidin and cytokeratin II negative and are
located in the BCL. d and e Highermagnification of the region delineated
by a white rectangle in a and b , respectively. The filled arrowheads in d
indicate the somata of some VRNs. The open arrowheads indicate the
apical endings of some VRNs (knobs). The open arrowheads in e
indicate the soma of a SC, the filled arrowheads point at the basal process
of the SC spanning the whole epithelium of the VNO. f Slice of another
VNO with propidium iodide-stained cell nuclei (red fluorescence) and
BrdU-positive cells (green fluorescence). The vast majority of BrdU
positive cells are confined to the BCL of the VNO. g Higher magnifica-
tion of the region delineated by a white rectangle in f . The filled arrow-
heads indicate BrdU-positive cells in the basalmost part of the epitheli-
um. Asterisks indicate BrdU-positive cells in the VRNL, most probably
maturing VRNs. Open arrowheads point at BrdU-positive SCs (see
typical elongated nucleus)
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extracellular Ca2+ was essential for the responses to ATP
(100 μM). In both cell populations, responses to ATP in
Ca2+-free bath solution were the same or larger than those in
standard solution (Fig. 4a). Similar results were obtained in 28
Fig. 2 ATP-induced [Ca2+]i increases in supporting and basal cells of the
epithelium of the VNO of larval Xenopus laevis. a Pseudocolored image
of an acute VNO slice stained with the Ca2+ indicator dye Fluo-4 (SCL
supporting cell layer; VRNL vomeronasal receptor neuron layer; BCL
basal cell layer). The upper left-hand image was acquired before appli-
cation of ATP. Application of ATP-induced [Ca2+]i transients in cells of
the BCL (open arrowheads) and SCL (filled arrowheads). No apparent
changes in Ca2+-dependent fluorescence in cells of the VRNL (upper
right-hand image). The lower left-hand image was taken after return to
the base line fluorescence. A pixel correlation map (see Materials and
methods for details) of the same slice is depicted in the lower right-hand
image. Responsive cells appear bright on dark background. b ATP-
induced [Ca2+]i transients of individual cells from the SCL (black traces).
Themagenta-colored area gives the mean [Ca2+]i transients ± SEM of all
individual SCs (n =20). c ATP-induced [Ca2+]i transients of individual
cells from the BCL (black traces). The green-colored area gives the
mean [Ca2+]i transients ± SEM of all individual BCs (n =20)
Fig. 3 Vomeronasal receptor neurons do not respond upon application of
ATP. a A micro-Ruby backfilled and Fluo-4 stained acute slice of the
vomeronasal organ (red VRNs; green Fluo-4 stained cells; SCL
supporting cell layer; VRNL vomeronasal receptor neuron layer; BCL
basal cell layer). b ATP and high K+-induced [Ca2+]i transients of
individual micro-Ruby backfilled cells (i.e., VRNs; black traces). The
red -colored areas give the mean [Ca2+]i transients ± SEM of all
individual VRNs (n =9). The VRNs did not respond upon application
of ATP, but all responded upon stimulation with high K+ solution. c ATP
and high K+-induced [Ca2+]i transients of individual non-neuronal cells
(i.e., micro-Ruby negative cells from the SCL and BCL). The cyan-
colored areas give the mean [Ca2+]i transients ± SEM of all individual
non-neuronal cells (n=11). Non-neuronal cells responded upon applica-
tion of ATP, but did not respond upon stimulation with high K+
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SCs and 61 BCs (four VNO slices, respectively) tested
(Fig. 4b). On the other hand, depleting intracellular Ca2+
stores with CPA (10 μM) eliminated the intracellular Ca2+
responses to ATP almost completely in both cell populations
(Fig. 4c). Virtually identical results were obtained in all of the
11 SCs and 51 BCs (two and four VNO slices, respectively)
tested (Fig. 4d). Together, these data show that the ATP-
induced [Ca2+]i increases in SCs and BCs were mediated by
Ca2+ release from CPA-sensitive intracellular stores, and that
extracellular Ca2+ contributed little, if at all. Furthermore, the
P2 receptor-antagonist suramin, applied at a concentration of
200 μM, differentially affected the ATP-induced [Ca2+]i in-
creases in SCs and BCs (Fig. 4e and f). Responses of SCs
were not affected by suramin (10 SCs; two VNO slices). The
Fig. 4 ATP-induced [Ca2+]i increases of supporting and basal cells do
not depend on extracellular Ca2+ but are dependent of store depletion, and
are differentially affected by the purinergic antagonist suramin. a ATP-
induced [Ca2+]i increases of SCs (magenta) and BCs (green ; mean
response ± SEM of all ATP-responsive cells of an acute slice of the
VNO; SCL supporting cell layer; BCL basal cell layer) persisted in
Ca2+-free bath solution (gray-shaded rectangle ; ATP application after
9 min in Ca2+-free bath solution). b Mean maximum responses ± SEM,
expressed as percent of control response to ATP, of 28 SCs and 61 BCs
(four VNO slices) in standard (magenta and green columns, respectively)
and Ca2+-free bath solution (light magenta and light green columns , 3, 6,
and 9 min in Ca2+-free bath solution, respectively). c ATP-induced
[Ca2+]i increases of SCs (magenta) and BCs (green ; mean response ±
SEM of all ATP-responsive cells of an acute slice of the VNO) were
reversibly inhibited by depletion of intracellular Ca2+ stores with CPA
(10 μM, gray-shaded rectangle ; ATP application after 9 min in bath
solution with CPA). d Mean maximum responses ± SEM, expressed as
percent of control response to ATP, of 11 SCs (two slices) and of 51 BCs
(four slices) in standard (magenta and green columns, respectively) and
bath solution with CPA (light magenta and light green columns , 3, 6, and
9 min in bath solution with CPA, respectively). e ATP-induced [Ca2+]i
increases of SCs (magenta) and BCs (green ; mean response ± SEM of all
ATP-responsive cells of an acute slice of the VNO) were differentially
affected by suramin (SUR , 200 μM, gray-shaded rectangle ; ATP appli-
cation after 9 min in bath solution with suramin). While ATP-induced
[Ca2+]i increases of SCs were unaffected by suramin, the responses of
BCs showed a consistent reduction in bath solution with suramin. f Mean
maximum responses ± SEM, expressed as percent of control response to
ATP, of 10 SCs (two slices) and of 69 BCs (seven slices) in standard
(magenta and green columns , respectively) and bath solution with
suramin (light magenta and light green columns, 3, 6, and 9 min in bath
solution with suramin, respectively). Statistical significance was tested
using paired Student’s t test (*p<0.05; **p<0.01)
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mean ATP-induced [Ca2+]i increase in BCs, in turn, was
consistently reduced in the presence of suramin (69 BCs;
seven VNO slices).
To obtain an indication on the specific purinergic receptor
subtype(s) expressed by SCs and BCs, we tested the potency
of a variety of purinergic agonists known to differentially
activate purinergic receptors. [Ca2+]i responses upon applica-
tion of various purinergic agonists (each 100 μM) are shown
in Fig. 5a and c, respectively. The bar graphs in Fig. 5 sum-
marize the data obtained from 131 SCs (14 VNO slices;
Fig. 5b) and 429 BCs (30 VNO slices; Fig. 5d). In addition
to ATP, all SCs responded also to UTP and ATPγS, with an
order of agonist potency of ATP > UTP > ATPγS. UTP was
similarly potent as ATP (taken as 100 %), with mean maxi-
mum amplitudes of 69±16 %. ATPγS was not as potent as
ATP, with mean maximum amplitudes of 35±7 %. All of the
responsive SCs tested responded to these three purinergic
agonists. In a subset of SCs, some irregular and faint responses
were obtained also upon application of UDP and to a much
lesser extent upon application of ADP. All other agonists
tested, i.e., adenosine, 2-MeSADP, 2-MeSATP, BzATP, α,β-
meATP, and β,γ-meATP were inactive. The response profile
of BCs, on the other hand, was considerably broader. In
addition to ATP, BCs responded to ADP, 2-MeSATP, 2-
MeSADP, ATPγS, UTP, and UDP. 2-MeSADP, ADP, and
ATPγS were nearly equipotent to ATP (taken as 100 %), with
maximum amplitudes of 91±7, 80±7, and 76±11 %, respec-
tively. 2-MeSATP, UDP, and UTP were not as effective as
ATP with maximum amplitudes of 57±11, 54±4, and 50±
7 %, respectively. The determined order of agonist potency
Fig. 5 Differential
responsiveness of supporting cells
and basal cells to purinergic
agonists. a [Ca2+]i increases of
SCs in response to application of
various purinergic agonists (each
100 μM; mean response ± SEM
of all ATP-responsive cells of
VNO slices; traces originate from
more than one slice). b Mean
maximum responses ± SEM,
expressed as percent of control
response to ATP (ATP data from
131 SCs from 14 VNO slices;
ADP 47/5; adenosine 29/3; 2-
MeSATP 55/6; 2-MeSADP 64/7;
ATPγS 47/5; BzATP 50/6; UTP
80/8; UDP 47/5; α,β-meATP 9/
2; β,γ-meATP 9/2). c [Ca2+]i
increases of BCs in response to
application of various purinergic
agonists (each 100 μM; mean
response ± SEM of all ATP-
responsive cells of VNO slices;
traces originate from more than
one slice). d Mean maximum
responses ± SEM, expressed as
percent of control response to
ATP (ATP data from 429 BCs
from 30 VNO slices; ADP 214/
14; adenosine 122/7; 2-MeSATP
163/11; 2-MeSADP 291/19;
ATPγS 150/10; BzATP 105/7;
UTP 189/13; UDP 188/13; α,β-
meATP 81/4; andβ,γ-meATP 81/
4)
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was therefore: ATP ≥ 2-MeSADP ≥ ADP = ATPγS > UDP =
UTP = 2-MeSATP. The nucleoside adenosine, BzATP, α,β-
meATP, and β,γ-meATP were inactive. All of the individual
BCs tested had the above mentioned response profiles to the
applied agonists.
Discussion
Purinergic signaling is known to be widespread throughout
many tissues [22], including the central nervous system [23]
and the special senses [12]. Among the special senses, the role
of purinergic signaling in the olfactory system is certainly less
studied than in the visual, auditory, or gustatory system (for a
review see [12]). The olfactory system of tetrapod vertebrates
is generally organized in different subsystems including the
main and vomeronasal system, the septal organ and the
Grueneberg ganglion [5]. The olfactory epithelia of all classes
of tetrapods consist of the same three main cell types, i.e.,
receptor neurons, SCs, and BCs [5]. The presence of a
purinergic system in the MOE has so far only been reported
for amphibians [8, 9], and Murinae [10, 11, 18, 24]. The
available information about purinergic receptors in the VNO
is limited to two publications. Functional purinergic receptors
have been shown to be expressed on isolated mouse VRNs
[19], and an immunohistochemical study provided evidence
for purinergic receptor expression in VRNs and SCs of the rat
VNO [18]. In the present study, we describe the general
cellular organization of the VNO of the amphibian X. laevis
using tracing and immunohistochemical techniques and a
BrdU incorporation assay, and characterize the vomeronasal
purinergic system using functional calcium imaging.
Cellular organization of the vomeronasal epithelium
As in the MOE [8, 9], antibodies against cytokeratin type II
turned out to specifically stain SCs, but not VRNs and BCs of
the VNO of larval X. laevis . Supporting cells form a columnar
layer in themost apical part of the vomeronasal epithelium and
send thin processes across the whole width of the VNO. The
somata of VRNs, visualized by biocytin-backfills occupy an
intermediate zone of the epithelium. Proliferating BCs, visu-
alized by BrdU stainings, reside in the basalmost layer of the
epithelium. Sparse BrdU-positive cells were also present in the
most apical epithelial layer, showing that similarly, as in other
vertebrates [25], also SCs of the Xenopus VNO are able to
duplicate. The few BrdU-positive cells in the intermediate part
of the epithelium, most probably represent newly formed
immature VRNs. In the murine VNO, two types of BCs have
been described. Marginally situated BCs have been shown to
be responsible for the growth of the organ, BCs situated more
centrally have been associated with neuronal replacement
[26–28]. Whether different types of BCs exist also in the
VNO of Xenopus will be tackled in a future, more specific,
study. Together, these results show that the epithelium of the
Xenopus VNO is generally structured as its MOE [8, 9].
ATP-induced Ca2+ signaling in cells of the vomeronasal organ
Application of ATP to acute slices of the VNO induced strong
[Ca2+]i increases in both cells of the SCL and the BCL. As in
SCs of the larval Xenopus and mouse MOE [8, 11], also the
responses of SCs of the Xenopus VNO exhibited a wave-like
propagation pattern. Cells of the VRNL showed virtually no
response, strongly indicating that VRNs do not express
purinergic receptors coupled to signaling pathways leading to
increases in intracellular calcium concentration. Also ORNs of
larvalXenopus MOE do not express purinergic receptors [7, 8].
The lack of purinergic receptors on VRNs could further be
substantiated by calcium imaging in micro-Ruby backfilled
VNO slices. Backfilled VRNs never responded to ATP, but
responded to the application of bath solution with high K+.
Increases of [Ca2+]i upon stimulation with bath solution with
high K+ indicates the presence of voltage-dependent Ca2+
channels, which is indicative of neurons [29]. This is in stark
contrast to the murine olfactory system. Murine ORNs as well
as VRNs have been shown to express purinergic receptors [10,
18]. The activation of purinergic receptors in mouse ORNs and
VRNs has been shown to modulate their responsiveness to
odorants [10, 19]. Of course, our study does not exclude
that VRNs of the adult Xenopus olfactory system express
purinergic receptors. The ATP-induced [Ca2+]i increases in
SCs and BCs persisted in the absence of extracellular
Ca2+, but were virtually abolished after application of
CPA, a specific inhibitor of the sarcoplasmic–endoplasmic
reticulum Ca2+ ATPase [30], that leads to the depletion of
intracellular Ca2+ stores. This, in turn, is a strong indica-
tion that the ATP-induced [Ca2+]i increases in both cell
types are almost exclusively due to the activation of me-
tabotropic purinergic receptors coupled to store-dependent
Ca2+ release, most probably P2Y receptor subtypes. P2Y
receptors are a family of G protein coupled receptors
present in a multitude of species [31]. Most studies, how-
ever, focused on mammalian P2Y receptors. The mamma-
lian P2Y-receptor family comprises eight subtypes.
Among these, P2Y1, P2Y6, and P2Y12 are activated main-
ly by nucleoside diphosphates, while P2Y2 and P2Y4 are
selective for nucleoside triphosphates. P2Y2, P2Y4, and
P2Y6 subtypes are activated by both purines and pyrimi-
dines. P2Y1, P2Y11, and P2Y12 subtypes, in turn, show
selectivity for purines. More specifically, 2-MeSADP is
the most potent agonist at P2Y1, P2Y12, and P2Y13 recep-
tors, ATP and UTP are almost equipotent at P2Y2 and
P2Y4 receptors, P2Y6 has the highest affinity for UDP;
P2Y11 is best activated by ATPγS and UDP-glucose se-
lectively activates P2Y14 (for reviews see [22, 32, 33]).
334 Purinergic Signalling (2014) 10:327–336
Identification of purinergic receptor subtypes expressed
by supporting and basal cells
In an attempt to determine the P2Y receptor subtype(s) in-
volved, we compared the effect of ATPwith those of a number
of putative purinergic agonists. In addition to ATP, only UTP
and ATPγS activated all SCs of the VNO. Among all P2Y
receptors, only P2Y2 and P2Y4 subtypes have been reported
to be preferentially and almost equipotently activated by ATP
and UTP [22, 32]. Furthermore, ATPγS is known to activate
P2Y2 and P2Y4 receptors with a lower potency than ATP and
UTP [34, 35]. These data are a good indication that SCs of the
Xenopus VNO express P2Y2/P2Y4-like receptors. Some SCs
additionally responded to UDP and to a much lesser extent to
ADP. These responses, however, were quite irregular and
therefore not comparable to the responses to ATP, UTP, and
ATPγS. It is known that immature and mature cells often
express different purinergic receptor subtypes [36]. Therefore,
the observed responses to UDP and ADP could come from
immature SCs [25], transiently expressing a different set of
purinergic receptors if compared to mature SC. All responsive
BCs of the VNO were activated by ATP, ADP, 2-MeSATP, 2-
MeSADP, ATPγS, UTP, and UDP. The agonist profile and the
order of agonist potency (ATP ≥ 2-MeSADP ≥ADP =ATPγS
> UDP = UTP = 2-MeSATP) of the P2Y receptor(s) of BCs
does not match with any of the known agonist profiles of
individual mammalian P2Y receptors [22, 32, 33], and is also
not consistent with the agonist profile of P2Y8, a purinergic
receptor cloned from Xenopus [37]. The fact that BCs
responded to nucleoside diphosphates and triphosphates, and
their inability to discriminate between purines and pyrimi-
dines is a good indication that they express multiple P2Y
subtypes. Of course, we cannot exclude that SCs and BCs
express one or more not yet identified Xenopus -specific P2Y
subtype(s). The observation that the P2X receptor agonists α,
β-meATP and β,γ-meATP, as well as the P1 receptor agonist
adenosine [22, 38] were ineffective on both cell types (SCs
and BCs) further excludes an involvement of P2X and P1
receptors in purinergic signaling of the VNO. The non-
selective P2 receptor-antagonist suramin [32, 38], slightly
attenuated ATP-induced [Ca2+]i increases solely in BCs. The
responses of SCs were not affected at all. It has been shown
that high concentrations of suramin affect all P2Y subtypes
except P2Y4 [32]. Together with the agonist results, this
indicates that P2Y4 is very likely to be among the P2Y
subtypes expressed by BCs, and that SCs might express
functional P2Y4 rather than P2Y2 subtypes. Other possible
purinergic receptor subtypes expressed by BCs could be
P2Y1, P2Y6, P2Y12, and P2Y13 which are predominantly
activated either by nucleoside diphosphates or 2-MeSADP
[22, 32, 33].
Taken together, the present study is the first systematic
investigation of the purinergic system of an amphibian
VNO. We provide evidence that functional P2Y receptors
are expressed by non-neuronal cells (SCs and BCs), but not
by receptor neurons. These data show that SCs and BCs of the
Xenopus VNO and MOE express the same or very similar
purinergic receptor subtypes (cf. [8, 9]), suggesting that
purinergic signaling in both olfactory organs regulates similar
physiological processes. In the Xenopus , MOE purinergic
signaling has been shown to regulate cell proliferation of
olfactory progenitor cells [9]. It remains to be shown if the
purinergic system of the VNO serves a similar purpose. The
similarity with the responses in mouse SCs [11], in turn,
allows the speculation that some nucleotide-induced effects
appear to be a common feature of olfactory organs of diverse
vertebrate species. Unlike in the murine MOE and VNO [10,
18, 19], receptor neurons of both olfactory organs of Xenopus
appear not to express purinergic receptors. This, in turn,
clearly shows that also some fundamental differences exist
between the purinergic systems of the olfactory organs of
different vertebrate species.
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